Published “Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer” in New England Journal of Medicine — cited 1,831 times.
- #crossref
- #research
- #work
Published “Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer” in New England Journal of Medicine — cited 1,831 times.
Captured 2026-08-21 from Crossref. The archived copy is preserved so this citation survives link rot.